Last reviewed · How we verify
NCT05454943: READY
Remote Time-restricted EAting DeliverY
NA trial testing Standardized TRE Protocol in Metabolic Disturbance in 178 participants. Completed in 30 January 2024.
20 September 2023
Quick facts
| Lead sponsor | University of Toronto |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | single |
| Primary purpose | treatment |
| Enrollment | 178 |
| Start date | 7 July 2022 |
| Primary completion | 20 September 2023 |
| Estimated completion | 30 January 2024 |
| Sites | 1 location across Canada |
Drugs / interventions tested
- Standardized TRE Protocol
- Personalized TRE Protocol
- External Support for TRE
- Peer Support for TRE
Conditions studied
- Metabolic Disturbance — all drugs for Metabolic Disturbance →
Sponsor
University of Toronto
Who can join
50 and older, female only, with Metabolic Disturbance. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
This study will evaluate the implementation and effectiveness of free-living TRE on biological and behavioural breast cancer risk factors.
Publications & conference data
1 peer-reviewed publication reference this trial (live from Europe PMC):
-
Obesity, cancer risk, and time-restricted eating.
Das M, Webster NJG. · · 2022 · cited 25× · PMID 35984550 · DOI 10.1007/s10555-022-10061-3
Verify or expand the search:
- PubMed search for NCT05454943
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Metabolic Disturbance
Currently open trials in the same condition.
- NCT06454864 — Multiple Risk Factor Intervention Trial in Breast Cancer Survivors · NA · recruiting
- NCT06345937 — Multiple Risk Factor Intervention Trial (Ms. FIT) · NA · recruiting
- NCT06252922 — Diet-Induced Changes in GEnetic Material · recruiting
- NCT05919940 — Improved Muscle Metabolism by Combination of Muscle Activation and Protein Substitution ( IMEMPRO ) · NA · recruiting
- NCT05912348 — The Effects of an Obesogenic Lifestyle in Recreationally Active, Young Adults · NA · recruiting
Other University of Toronto trials
Trials by the same sponsor.
- NCT07184255 — Animated Video Education for Retinal Surgery · NA · not yet recruiting
- NCT07259434 — Time Restricted Eating in Survivors Trial 2.0 · NA · not yet recruiting
- NCT07486050 — The Impact of Social Worker Referrals on Diabetes and Loneliness · NA · active not recruiting
- NCT07268729 — Investigation of Pathogenic Gut Microbiota Patterns in Anxiety, Depression and Panic Disorders · not yet recruiting
- NCT07317921 — Validating IAAO for Muscle Outcomes · NA · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT05454943 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by University of Toronto
- Last refreshed: 1 October 2025
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05454943.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing